Pharmaceutical Executive October 25, 2024
Growth is expected due to increased instances of chronic diseases such as cancer and Alzheimer disease.
A new report by the Insight Partners projects that by 2031, the radiopharmaceutical market is expected to reach $26.51 billion, increasing from $9.07 billion in 2023 at a compound annual growth rate (CAGR) of 14.4%. According to the report, the increase will be driven by a growing number of chronic diseases such as cancer and Alzheimer disease.
The trend is particularly notable in developing countries where these diseases are becoming more common. In developed countries, advancements in technology and increasing healthcare expenditures are driving market expansion.1
“Many medical market players focus on emerging countries in Asia, South America, and Africa due to a rise...
Today's Sponsors
Today's Sponsor